3BNC117 and 10-1074 in HIV Uninfected Adults

NCT02824536 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Human Immunodeficiency Virus

Interventions

DRUG: 3BNC117
DRUG: 10-1074
DRUG: Placebo

Sponsor

Rockefeller University